David W Gryska Aerie Pharmaceuticals Inc (AERI) insider trading activity

AERI Quotes by TradingView

David W Gryska is Director of AERIE PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of AERI, which is worth approximately $0. The most recent transaction as insider was on Nov 21, 2022, when has been sold 11,495 shares (Common Stock) at a price of $15.25 per share, resulting in proceeds of $175,298. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

DAVID W GRYSKA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2022
SELL
Sale (or disposition) back to the issuer
$175,298 $15.25 p/Share
11,495 Reduced 100.0%
0 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
6,245 Added 35.2%
11,495 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
1,750 Added 25.0%
5,250 Common Stock

Also insider at

SGEN
Seagen Inc. Healthcare
PDLI
PDL BIOPHARMA, INC.
Director
FBRX
Forte Biosciences, Inc. Healthcare
Director
MNMD
Mind Medicine (MindMed) Inc. Healthcare
DWG

David W Gryska

Director
Bothell, WA

Track Institutional and Insider Activities on AERI

Follow AERIE PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AERI shares.

Notify only if

Insider Trading

Get notified when an Aerie Pharmaceuticals Inc insider buys or sells AERI shares.

Notify only if

News

Receive news related to AERIE PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AERI